Form 4: Insider Ali Behbahani Boosts SpyGlass Pharma Stake Post-IPO

SpyGlass Pharma Director and 10% owner Ali Behbahani reported significant acquisitions of common stock, including a direct purchase and conversions of preferred shares, following the company's IPO.

Summary

• Ali Behbahani, a Director and 10% owner of SpyGlass Pharma, Inc. (SGP), reported multiple transactions on February 9, 2026.
• These transactions included the automatic conversion of various series of preferred stock (Series B, C-1, C-2, D, A) into common stock, totaling 5,097,538 shares indirectly through NEA 17 and 1,357,263 shares indirectly through NEA 16.
• Additionally, Behbahani reported a direct purchase of 937,500 shares of common stock at a price of $16.00 per share.
• Following these transactions, the total indirect beneficial ownership of common stock stands at 7,392,301 shares (6,035,038 via NEA 17 and 1,357,263 via NEA 16).
• The preferred stock conversions occurred automatically on a one-for-one basis prior to the closing of SpyGlass Pharma's initial public offering (IPO) on February 9, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, given the significant insider acquisition of common stock, including a direct purchase, immediately following the IPO. This indicates high confidence from a key stakeholder.

Positives

• A Director and 10% owner acquired a substantial number of common shares, including a direct purchase, indicating strong confidence in the company's future.
• The conversion of preferred stock to common stock simplifies the capital structure post-IPO, which is a standard and positive development.
• The purchase price of $16.00 per share provides a clear valuation point for a significant insider transaction.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, but the timing of the transactions post-IPO suggests a strategic positioning by a significant insider.

Industry Context

StockSavvy.ai notes that insider purchases, especially by a Director and 10% owner shortly after an IPO, can signal strong internal confidence in the company's prospects. This activity is common for venture capital partners converting their holdings and making strategic purchases post-listing.

Comparison to Industry Standards

• StockSavvy.ai observes that significant insider buying post-IPO, particularly from a major institutional investor like New Enterprise Associates (NEA) via its managing partners, is generally viewed favorably.
• For example, similar post-IPO insider activity was seen with executives at companies like Snowflake (SNOW) or Palantir (PLTR) following their direct listings or IPOs, where early investors or founders converted holdings and sometimes made additional purchases, signaling long-term commitment.
• The $16.00 purchase price provides a benchmark for institutional conviction at the time of the IPO.

Related Party Transactions

• The transactions involve indirect beneficial ownership through New Enterprise Associates (NEA) funds (NEA 17 and NEA 16), where the reporting person, Ali Behbahani, is a manager of the general partner entities. While beneficial ownership is disclaimed for pecuniary interest, the reporting structure highlights the relationship.

Stakeholder Impact

• Shareholders: The significant insider buying by a Director and 10% owner, especially post-IPO, could instill confidence in existing and potential shareholders, suggesting strong belief in the company's valuation and future prospects.

Key Dates

Recommendation

The substantial acquisition of common stock by a Director and 10% owner, including a direct purchase at $16.00 per share, immediately following the company's IPO, signals strong insider confidence. This type of insider buying often precedes positive performance and suggests that key stakeholders believe the stock is undervalued or has significant growth potential. The conversion of preferred shares also streamlines the capital structure, further enhancing investor clarity.

Keywords

SpyGlass Pharma, SGP, Insider Trading, Form 4, Stock Acquisition, Preferred Stock Conversion, IPO, Ali Behbahani, New Enterprise Associates, NEA